Athersys to Present at Piper Jaffray 24th Annual Healthcare Conference
CLEVELAND, Nov. 19, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced that it will present at the Piper Jaffray 24th Annual Healthcare Conference, to be held Tuesday, November 27, 2012, through Wednesday, November 28, 2012, at The New York Palace in New York City.
William (B.J.) Lehmann, President and Chief Operating Officer is scheduled to present on Wednesday, November 28, 2012, at 3:00 p.m. Eastern Standard Time. A live audio webcast of the presentation will be available via the following link: http://www.media-server.com/m/p/84pfrc7b. Shortly thereafter, a webcast replay will be available via the Company's website at www.athersys.com in the Investors section.
Athersys is a clinical stage biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas. The Company currently has several clinical stage programs involving MultiStem, including for treating inflammatory bowel disease, ischemic stroke, damage caused by myocardial infarction, and for the prevention of graft-versus-host disease. Athersys has also developed a diverse portfolio that includes other technologies and product development opportunities, and has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions in the United States and Europe to further develop its platform and products. More information is available at www.athersys.com.
The Athersys, Inc. logo is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=4548
CONTACT: William (B.J.) Lehmann, J.D. President and Chief Operating Officer Tel: (216) 431-9900 firstname.lastname@example.org Investor Relations: Lisa M. Wilson In-Site Communications Tel: (917) 543-9932 email@example.com